Saturday, October 12, 2024 from 10:00 AM to 11:30 AM MST at Convention Center North Building / North Ballroom 120A
Available for 1.50 hours of CPE creditActivity Number: 0217-0000-24-200-L99-PActivity Type: A Knowledge-Based ActivityThe opioid epidemic and deaths from overdose continue to be a public health crisis. This session will summarize ACCP’s advocacy efforts as well as explore emerging opioid policy and interprofessional efforts to expand access to opioid use disorder treatment. Attendees will learn about the team-based treatment of opioid use disorder in a value-based care model. Attendees will be encouraged to share how they are engaging in opioid policy or practice advancement at the local or institutional level, as well as identify gaps in opioid policy that affect patient access to clinical pharmacy services.
Learning Objectives1. Summarize ACCP’s advocacy efforts in advancing clinical pharmacy services for the management of substance use disorder and addiction.
2. Discuss legislative efforts to combat the opioid crisis and the potential implications of the upcoming 2024 elections.
3. Review team-based treatment models of opioid use disorder to identify key components and best practices that enhance patient outcomes and collaborative care efforts.
4. Identify common barriers that restrict access to clinical pharmacy services for managing opioid use disorder.
What Can ACCP Do?10:00 AM to 10:30 AM | | Speaker: | Katherine D. Pham, Pharm.D., BCPPS | | Senior Director, Policy and Professional Affairs, American College of Clinical Pharmacy (ACCP), Washington, D.C. | | View Biography |
|
|
What Can Lawmakers Do?10:30 AM to 11:00 AM | | Speaker: | Paul T. Kelly | | President, Capitol Advocacy and Government Affairs, LLC, Washington, D.C.
| | View Biography |
|
|
What Can Clinical Pharmacists Do?11:00 AM to 11:30 AM |